Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

High survival rates in localized kidney cancer contrast with patients' uncertainty about their prognosis, affecting their quality of life. The distinction between feeling "cured" and "consumed" by ...

A new survey highlights a growing “clinical interpretation gap” as patients increasingly rely on digital tools to ...